Newcastle Clinical Trials Unit

Apple COPD

Apple COPD

Anti-platelet Therapy in the Primary Prevention of CardiovascuLar DisEase in Patients with Chronic Obstructive Pulmonary Disease

Status: Closed
Sponsor: The Newcastle upon Tyne Hospitals NHS Foundation Trust
Funder: Astra Zeneca
Therapeutic area: Cardiovascular
Type of study: CTIMP

Aim: To investigate if treatment with antiplatelet therapy (APT) will produce a response in platelet function measured using the Multiplate test in patients with chronic obstructive pulmonary disease (COPD).

Primary Outcome:

Inhibition of ASPI and ADP-induced platelet aggregation at 6-month

Population: Adult
Design: RCT
Setting: Secondary Care
Planned Sample Size: 120